Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dihexyverine is a small molecule antispasmodic and smooth muscle relaxant belonging to the piperidine class. It acts primarily as an antimuscarinic (muscarinic acetylcholine receptor antagonist), leading to relaxation of smooth muscle in the gastrointestinal and genitourinary tracts. Its main clinical use is for the treatment of functional gastrointestinal disorders such as irritable bowel syndrome, spastic colon, and related conditions. Dihexyverine exerts its effects by inhibiting muscarinic acetylcholine receptors, thereby reducing parasympathetic nervous system activity and alleviating spasms[1][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dihexyverine.